Analysts acknowledged the long-term manufacturing deal could dull Viking’s takeout prospects but hailed it as a smart move to ensure supply.

“While bananas don’t contain high levels of melatonin directly, they are rich in nutrients that support melatonin production ...

The latest news on President Donald Trump’s administration as the House is expected to vote on a continuing resolution to ...

These are the 41 best, fully tested sleep products of 2025. The average person spends approximately a third of their life ...

Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after ...

Acelyrin (NASDAQ:SLRN) stock in focus as the company adopts a poison pill to counter rapid stock acquisition by Tang Capital Partners. Read more here.

The late-stage biopharma said the plan will issue one right for each share of common stock as of the close of business on March 24. The rights will initially trade with its common stock, and will ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

The new entity will be listed on the New York Stock Exchange and is expected to generate pro forma revenue of $3.6 billion in ...

Viking Therapeutics is partnering with Germany's CordenPharma to produce 1 billion GLP-1 pills a year and 100 million ... Despite these developments, Novo Nordisk stock remains the most ...

Let's take a closer look at its recent earnings and restructuring plan to see if the company has ... Given its low stock price which has been cut in half over the past year, that just leads ...